Wilmington, Delaware, United States, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - According to a market report by TMR, the global germanium ...
New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Gallium-68 Market Research Report 2022-2032" - https://www ...
BERLIN--(BUSINESS WIRE)--Eckert & Ziegler Radiopharma GmbH has received approval from the Federal Institute for Drugs and Medical Devices (BfArM) for its pharmaceutical 68 Ge/ 68 Ga generator for the ...
FLEURUS, Belgium and MONTREAL, Dec. 5, 2019 /CNW Telbec/ - IRE ELIT, Belgian radiopharmaceutical company, has just received the Notice of Compliance (NOC) from Health Canada for its drug Galli Eo, the ...
BERLIN--(BUSINESS WIRE)--Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler AG, has been given the manufacturing authorization for its pharmaceutical 68 Ge/ 68 Ga generators at the ...
Chennai, July 5 (IANS) Russia’s integrated nuclear power major Rosatom said Isotope – Regional Alliance JSC has delivered the first shipment of germanium-68 ...
QEII Foundation donors are bringing Atlantic Canada’s first gallium-68 DOTATATE tracer to the QEII to help diagnose and treat patients with neuroendocrine cancer Sharon Needham never expected to see ...
The issuer is solely responsible for the content of this announcement. "We are pleased to now be able to offer GalliaPharm (R) in Canada. Meanwhile, the generators from Eckert & Ziegler are available ...
This Coordinated Research Project is the result of recommendations from the scientific community through interactions with IAEA technical officers. Prostate cancer is the most common solid malignancy ...
The issuer is solely responsible for the content of this announcement. Berlin, 18 November 2021. Eckert & Ziegler Radiopharma GmbH has received approval for its pharmaceutical 68 Ge/ 68 Ga generator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback